[go: up one dir, main page]

FR2361895B1 - - Google Patents

Info

Publication number
FR2361895B1
FR2361895B1 FR7625326A FR7625326A FR2361895B1 FR 2361895 B1 FR2361895 B1 FR 2361895B1 FR 7625326 A FR7625326 A FR 7625326A FR 7625326 A FR7625326 A FR 7625326A FR 2361895 B1 FR2361895 B1 FR 2361895B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7625326A
Other versions
FR2361895A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7625326A priority Critical patent/FR2361895A1/fr
Priority to SE7708626A priority patent/SE7708626L/xx
Priority to IL52709A priority patent/IL52709A/xx
Priority to SU772511698A priority patent/SU700065A3/ru
Priority to LU77993A priority patent/LU77993A1/xx
Priority to AU28062/77A priority patent/AU510300B2/en
Priority to ES461764A priority patent/ES461764A1/es
Priority to DK369677A priority patent/DK369677A/da
Priority to CH1022777A priority patent/CH626088A5/fr
Priority to GB34847/77A priority patent/GB1584398A/en
Priority to DE19772737504 priority patent/DE2737504A1/de
Priority to PT66944A priority patent/PT66944B/fr
Priority to ZA00775039A priority patent/ZA775039B/xx
Priority to AT601677A priority patent/AT357671B/de
Priority to IE1748/77A priority patent/IE45865B1/en
Priority to BE180282A priority patent/BE857933A/fr
Priority to JP10007077A priority patent/JPS5325595A/ja
Priority to NL7709258A priority patent/NL7709258A/xx
Publication of FR2361895A1 publication Critical patent/FR2361895A1/fr
Application granted granted Critical
Publication of FR2361895B1 publication Critical patent/FR2361895B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7625326A 1976-08-20 1976-08-20 Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments Granted FR2361895A1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR7625326A FR2361895A1 (fr) 1976-08-20 1976-08-20 Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
SE7708626A SE7708626L (sv) 1976-08-20 1977-07-27 Sett att framstella oximderivat av 3-karbamoyloximetyl-7-aminotiazolyl-acetamidocefalosporansyra
IL52709A IL52709A (en) 1976-08-20 1977-08-12 3-carbamoyloxymethyl-7-(2-amino-thiazol-4-yl)-(2-alkoxyimino)acetamido)ceph-3-em-4-carboxylic acids,process for preparing them and pharmaceutical compositions containing them
SU772511698A SU700065A3 (ru) 1976-08-20 1977-08-16 Способ получени производных 3-карбамоилоксиметил-7-аминотиазолил ацетамидоцеф-3-ем-4-карбоновой кислоты в виде син-изомеров, или их солей
GB34847/77A GB1584398A (en) 1976-08-20 1977-08-19 Oxime derivatives of 3-carbamoyloxymethyl-7-amino-thiazolyl-acetamido-ceph-3-em-4-carboxylic acid processes for preparing them and pharmaceutical compositions containing them
ES461764A ES461764A1 (es) 1976-08-20 1977-08-19 Procedimiento para preparar oximas derivadas del acido 3- carbamoiloximetil-7-aminotiazolilacetamido cefalosporanico.
DK369677A DK369677A (da) 1976-08-20 1977-08-19 Fremgangsmaade til fremstilling af oximderivater af 3-carbamoyloxymethyl-7-aminothiazolylacetamidocephalosponsyre
CH1022777A CH626088A5 (en) 1976-08-20 1977-08-19 Process for the preparation of new oximes derived from 3-carbamoyloxymethyl-7-(aminothiazolylacetamido)cephalosporanic acid
LU77993A LU77993A1 (fr) 1976-08-20 1977-08-19
DE19772737504 DE2737504A1 (de) 1976-08-20 1977-08-19 Derivate der 3-carbamoyloxymethyl-7- aminothiazolyl-acetamido-cephalosporansaeure, ihr herstellungsverfahren sowie pharmazeutische zusammensetzungen
PT66944A PT66944B (fr) 1976-08-20 1977-08-19 Procede de preparation de nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique
ZA00775039A ZA775039B (en) 1976-08-20 1977-08-19 New oxime derivatives of 3-carbamoylox methyl 7-amino thiazolyl acetamido cephalosporanic acid,a process for preparing them,and pharmaceutical compositions containing them
AT601677A AT357671B (de) 1976-08-20 1977-08-19 Verfahren zur herstellung von neuen oxim- derivaten der 3-carbamoyloxymethyl-7-amino- thiazolylacetamido-cephalosporansaeure
IE1748/77A IE45865B1 (en) 1976-08-20 1977-08-19 New oxime derivatives of 3-carbamoyloxymethyl-7-amino-thiazolyl-acetamido-cephalosporanic acid, processes for preparing them and pharmaceutical compositions containing them
BE180282A BE857933A (fr) 1976-08-20 1977-08-19 Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique
AU28062/77A AU510300B2 (en) 1976-08-20 1977-08-19 7-amino thiazolylacetamido cephalosporanic
JP10007077A JPS5325595A (en) 1976-08-20 1977-08-20 Production of novel oxime derivative of 33carbamoyloxymethyll 77aminothiazolylacetamido cephalosporanic acid and pharmaceutical composition
NL7709258A NL7709258A (nl) 1976-08-20 1977-08-22 Werkwijze ter bereiding van nieuwe oximen van 3-carbamoyloxymethyl 7-aminothiazolylaceet- amidocefalosporaanzuur.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7625326A FR2361895A1 (fr) 1976-08-20 1976-08-20 Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
FR2361895A1 FR2361895A1 (fr) 1978-03-17
FR2361895B1 true FR2361895B1 (fr) 1978-12-15

Family

ID=9177033

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7625326A Granted FR2361895A1 (fr) 1976-08-20 1976-08-20 Nouvelles oximes derivees de l'acide 3-carbamoyloxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments

Country Status (18)

Country Link
JP (1) JPS5325595A (fr)
AT (1) AT357671B (fr)
AU (1) AU510300B2 (fr)
BE (1) BE857933A (fr)
CH (1) CH626088A5 (fr)
DE (1) DE2737504A1 (fr)
DK (1) DK369677A (fr)
ES (1) ES461764A1 (fr)
FR (1) FR2361895A1 (fr)
GB (1) GB1584398A (fr)
IE (1) IE45865B1 (fr)
IL (1) IL52709A (fr)
LU (1) LU77993A1 (fr)
NL (1) NL7709258A (fr)
PT (1) PT66944B (fr)
SE (1) SE7708626L (fr)
SU (1) SU700065A3 (fr)
ZA (1) ZA775039B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2367756B1 (fr) * 1976-04-12 1985-07-05 Fujisawa Pharmaceutical Co Derives 2-alcoxyamino-2-(amino-1,3-thiazolyl) acetiques et leur utilisation
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
SE445350B (sv) * 1978-04-14 1986-06-16 Roussel Uclaf Oximderivat av 3-azidometyl-7-amino-tiazolyl-acetamido-cefalosporansyra och dess anvendning som antibiotika
IL61458A0 (en) * 1979-12-07 1980-12-31 Erba Farmitalia N-substituted thiazolyl derivatives of oximino-substituted cephalosporins, their preparation and pharmalceutical compositions containing them
FR2475043A2 (fr) * 1980-02-06 1981-08-07 Roussel Uclaf Nouvelles oximes derivees de l'acide 2-(2-amino protege 4-thiazolyl) acetique, leur procede de preparation et leur application
NO832376L (no) * 1982-06-30 1984-01-02 Glaxo Group Ltd Cephalosporin-antibiotika.
JPS60190783A (ja) * 1983-12-21 1985-09-28 Sumitomo Seiyaku Kk セフエム系化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds

Also Published As

Publication number Publication date
ZA775039B (en) 1978-09-27
IE45865L (en) 1978-02-20
IL52709A (en) 1981-01-30
GB1584398A (en) 1981-02-11
NL7709258A (nl) 1978-02-22
ES461764A1 (es) 1978-09-01
PT66944B (fr) 1979-11-12
LU77993A1 (fr) 1978-04-27
SE7708626L (sv) 1978-02-21
JPS5325595A (en) 1978-03-09
DK369677A (da) 1978-02-21
IL52709A0 (en) 1977-10-31
PT66944A (fr) 1977-09-01
IE45865B1 (en) 1982-12-15
DE2737504A1 (de) 1978-02-23
AT357671B (de) 1980-07-25
FR2361895A1 (fr) 1978-03-17
AU2806277A (en) 1979-02-22
ATA601677A (de) 1979-12-15
AU510300B2 (en) 1980-06-19
BE857933A (fr) 1978-02-20
SU700065A3 (ru) 1979-11-25
CH626088A5 (en) 1981-10-30

Similar Documents

Publication Publication Date Title
FR2361895B1 (fr)
FR2369039B1 (fr)
JPS5543412Y2 (fr)
CH612271A5 (fr)
CH599375A5 (fr)
CH613611A5 (fr)
CH613566A5 (fr)
CH595518A5 (fr)
CH595114A5 (fr)
CH613305A5 (fr)
CH595040A5 (fr)
CH594942A5 (fr)
CH613285A5 (fr)
CH613172A5 (fr)
CH613111A5 (fr)
CH593483A5 (fr)
CH612472A5 (fr)
CH590470A5 (fr)
BG23459A1 (fr)
CH612126A5 (fr)
CH611496A5 (fr)
CH596863A5 (fr)
CH611089A5 (fr)
CH611045A5 (fr)
CH608888A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse